| Year |
Citation |
Score |
| 2023 |
Gotkine M, Caraco Y, Lerner Y, Blotnick S, Wanounou M, Slutsky SG, Chebath J, Kuperstein G, Estrin E, Ben-Hur T, Hasson A, Molakandov K, Sonnenfeld T, Stark Y, Revel A, ... Revel M, et al. Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial results. Journal of Translational Medicine. 21: 122. PMID 36788520 DOI: 10.1186/s12967-023-03903-3 |
0.757 |
|
| 2021 |
Izrael M, Molakandov K, Revel A, Slutsky SG, Sonnenfeld T, Weiss JM, Revel M. Astrocytes Downregulate Inflammation in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: Applicability to COVID-19. Frontiers in Medicine. 8: 740071. PMID 34778302 DOI: 10.3389/fmed.2021.740071 |
0.756 |
|
| 2020 |
Izrael M, Slutsky SG, Revel M. Rising Stars: Astrocytes as a Therapeutic Target for ALS Disease. Frontiers in Neuroscience. 14: 824. PMID 32848579 DOI: 10.3389/Fnins.2020.00824 |
0.74 |
|
| 2018 |
Izrael M, Slutsky SG, Admoni T, Cohen L, Granit A, Hasson A, Itskovitz-Eldor J, Krush Paker L, Kuperstein G, Lavon N, Yehezkel Ionescu S, Solmesky LJ, Zaguri R, Zhuravlev A, Volman E, ... ... Revel M, et al. Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1 and NSG animal models. Stem Cell Research & Therapy. 9: 152. PMID 29871694 DOI: 10.1186/S13287-018-0890-5 |
0.751 |
|
| 2010 |
Amit M, Chebath J, Margulets V, Laevsky I, Miropolsky Y, Shariki K, Peri M, Blais I, Slutsky G, Revel M, Itskovitz-Eldor J. Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells. Stem Cell Reviews. 6: 248-59. PMID 20431964 DOI: 10.1007/S12015-010-9149-Y |
0.361 |
|
| 2010 |
Kazma M, Izrael M, Revel M, Chebath J, Yanai J. Survival, differentiation, and reversal of heroin neurobehavioral teratogenicity in mice by transplanted neural stem cells derived from embryonic stem cells. Journal of Neuroscience Research. 88: 315-23. PMID 19746435 DOI: 10.1002/Jnr.22193 |
0.37 |
|
| 2008 |
Revel M. Research on human embryonic stem cells and cloning for stem cells. Human Reproduction and Genetic Ethics. 14: 4-14. PMID 18655360 DOI: 10.1558/Hrge.V14I1.4 |
0.312 |
|
| 2008 |
Callizot N, Andriambeloson E, Glass J, Revel M, Ferro P, Cirillo R, Vitte PA, Dreano M. Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity. Cancer Chemotherapy and Pharmacology. 62: 995-1007. PMID 18270703 DOI: 10.1007/S00280-008-0689-7 |
0.303 |
|
| 2007 |
Zhang PL, Levy AM, Ben-Simchon L, Haggiag S, Chebath J, Revel M. Induction of neuronal and myelin-related gene expression by IL-6-receptor/IL-6: a study on embryonic dorsal root ganglia cells and isolated Schwann cells. Experimental Neurology. 208: 285-96. PMID 17963753 DOI: 10.1016/J.Expneurol.2007.08.022 |
0.743 |
|
| 2007 |
Izrael M, Zhang P, Kaufman R, Shinder V, Ella R, Amit M, Itskovitz-Eldor J, Chebath J, Revel M. Human oligodendrocytes derived from embryonic stem cells: Effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Molecular and Cellular Neurosciences. 34: 310-23. PMID 17196394 DOI: 10.1016/J.Mcn.2006.11.008 |
0.745 |
|
| 2006 |
Zhang PL, Izrael M, Ainbinder E, Ben-Simchon L, Chebath J, Revel M. Increased myelinating capacity of embryonic stem cell derived oligodendrocyte precursors after treatment by interleukin-6/soluble interleukin-6 receptor fusion protein. Molecular and Cellular Neurosciences. 31: 387-98. PMID 16325417 DOI: 10.1016/J.Mcn.2005.10.014 |
0.749 |
|
| 2004 |
Zvibel I, Brill S, Kariv R, Traister A, Golan T, Chebath J, Halpern Z, Revel M, Oren R. Chimeric molecule IL-6/soluble IL-6 receptor is a potent mitogen for fetal hepatocytes. Journal of Cellular Physiology. 200: 245-52. PMID 15174094 DOI: 10.1002/Jcp.20019 |
0.321 |
|
| 2004 |
Zhang P, Chebath J, Lonai P, Revel M. Enhancement of oligodendrocyte differentiation from murine embryonic stem cells by an activator of gp130 signaling. Stem Cells (Dayton, Ohio). 22: 344-54. PMID 15153611 DOI: 10.1634/Stemcells.22-3-344 |
0.739 |
|
| 2004 |
Kamaraju AK, Adjalley S, Zhang P, Chebath J, Revel M. C/EBP-delta induction by gp130 signaling. Role in transition to myelin gene expressing phenotype in a melanoma cell line model. The Journal of Biological Chemistry. 279: 3852-61. PMID 14600146 DOI: 10.1074/Jbc.M310443200 |
0.748 |
|
| 2003 |
Kollet O, Shivtiel S, Chen YQ, Suriawinata J, Thung SN, Dabeva MD, Kahn J, Spiegel A, Dar A, Samira S, Goichberg P, Kalinkovich A, Arenzana-Seisdedos F, Nagler A, Hardan I, ... Revel M, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. The Journal of Clinical Investigation. 112: 160-9. PMID 12865405 DOI: 10.1172/Jci17902 |
0.312 |
|
| 2003 |
Slutsky SG, Kamaraju AK, Levy AM, Chebath J, Revel M. Activation of myelin genes during transdifferentiation from melanoma to glial cell phenotype. The Journal of Biological Chemistry. 278: 8960-8. PMID 12643284 DOI: 10.1074/Jbc.M210569200 |
0.773 |
|
| 2002 |
Kamaraju AK, Bertolotto C, Chebath J, Revel M. Pax3 down-regulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling. The Journal of Biological Chemistry. 277: 15132-41. PMID 11830592 DOI: 10.1074/Jbc.M200004200 |
0.368 |
|
| 2001 |
Gurari-Rotman D, Marks Z, Chevath J, Revel M, Maroudas NG. Test of a novel transparent floating carrier by recombinant cho cells expressing sIL6 receptor protein. Cytotechnology. 37: 75-81. PMID 19002904 DOI: 10.1023/A:1019914630465 |
0.352 |
|
| 2001 |
Fisher J, Mizrahi T, Schori H, Yoles E, Levkovitch-Verbin H, Haggiag S, Revel M, Schwartz M. Increased post-traumatic survival of neurons in IL-6-knockout mice on a background of EAE susceptibility. Journal of Neuroimmunology. 119: 1-9. PMID 11525794 DOI: 10.1016/S0165-5728(01)00342-3 |
0.317 |
|
| 2001 |
Haggiag S, Zhang PL, Slutzky G, Shinder V, Kumar A, Chebath J, Revel M. Stimulation of myelin gene expression in vitro and of sciatic nerve remyelination by interleukin-6 receptor-interleukin-6 chimera. Journal of Neuroscience Research. 64: 564-74. PMID 11398179 DOI: 10.1002/Jnr.1108 |
0.739 |
|
| 1999 |
Haggiag S, Chebath J, Revel M. Induction of myelin gene expression in Schwann cell cultures by an interleukin-6 receptor-interleukin-6 chimera. Febs Letters. 457: 200-204. PMID 10471778 DOI: 10.1016/S0014-5793(99)01040-6 |
0.413 |
|
| 1999 |
Kollet O, Aviram R, Chebath J, Ben-Hur H, Nagler A, Shultz L, Revel M, Lapidot T. The soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro maintenance and proliferation of human CD34+CD38(-/low) cells capable of repopulating severe combined immunodeficiency mice Blood. 94: 923-931. PMID 10419883 DOI: 10.1182/Blood.V94.3.923.415K08_923_931 |
0.345 |
|
| 1999 |
Altschuler L, Wook J, Gurari D, Chebath J, Revel M. Involvement of receptor-bound protein methyltransferase PRMT1 in antiviral and antiproliferative effects of type I interferons. Journal of Interferon and Cytokine Research. 19: 189-195. PMID 10090404 DOI: 10.1089/107999099314333 |
0.357 |
|
| 1998 |
Mendel I, Katz A, Kozak N, Ben-Nun A, Revel M. Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. European Journal of Immunology. 28: 1727-37. PMID 9603480 DOI: 10.1002/(Sici)1521-4141(199805)28:05<1727::Aid-Immu1727>3.0.Co;2-# |
0.308 |
|
| 1997 |
Bornstein J, Lahat N, Kinarty A, Revel M, Abramovici H, Shapiro S. Interferon-beta and -gamma, but not tumor necrosis factor-alpha, demonstrate immunoregulatory effects on carcinoma cell lines infected with human papillomavirus. Cancer. 79: 924-34. PMID 9041155 DOI: 10.1002/(Sici)1097-0142(19970301)79:5<924::Aid-Cncr9>3.0.Co;2-B |
0.307 |
|
| 1997 |
Abramovich C, Yakobson B, Chebath J, Revel M. A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptor The Embo Journal. 16: 260-266. PMID 9029147 DOI: 10.1093/Emboj/16.2.260 |
0.33 |
|
| 1996 |
Oh JW, Revel M, Chebath J. A SOLUBLE INTERLEUKIN 6 RECEPTOR ISOLATED FROM CONDITIONED MEDIUM OF HUMAN BREAST CANCER CELLS IS ENCODED BY A DIFFERENTIALLY SPLICED mRNA Cytokine. 8: 401-409. PMID 8726669 DOI: 10.1006/Cyto.1996.0055 |
0.346 |
|
| 1996 |
Miller A, Lanir N, Shapiro S, Revel M, Honigman S, Kinarty A, Lahat N. Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseases. Journal of Neuroimmunology. 64: 151-61. PMID 8632057 DOI: 10.1016/0165-5728(95)00164-6 |
0.336 |
|
| 1995 |
Harroch S, Gothelf Y, Revel M, Chebath J. 5′ upstream sequences of MyD88, an IL-6 primary response gene in M1 cells: detection of functional IRF-1 and Stat factors binding sites Nucleic Acids Research. 23: 3539-3546. PMID 7567467 DOI: 10.1093/Nar/23.17.3539 |
0.34 |
|
| 1994 |
Abramovich C, Ratovitski E, Lundgren E, Revel M. Identification of mRNAs encoding two different soluble forms of the human interferon α-receptor Febs Letters. 338: 295-300. PMID 8307198 DOI: 10.1016/0014-5793(94)80287-4 |
0.348 |
|
| 1994 |
Rabau M, Kashtan H, Baron S, Yossiphov J, Skornik Y, Revel M, Eisenthal A. Inhibition of CT-26 murine adenocarcinoma growth in the rectum of mice treated with recombinant human interleukin-6. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 15: 257-64. PMID 8061898 DOI: 10.1097/00002371-199405000-00004 |
0.304 |
|
| 1994 |
Abramovich C, Chebath J, Revel M. The human interferon α-receptor protein confers differential responses to human interferon-β versus interferon-α subtypes in mouse and hamster cell transfectants Cytokine. 6: 414-424. PMID 7948750 DOI: 10.1016/1043-4666(94)90066-3 |
0.352 |
|
| 1994 |
Givon T, Revel M, Slavin S. Potential use of interleukin-6 in bone marrow transplantation: effects of recombinant human interleukin-6 after syngeneic and semiallogeneic bone marrow transplantation in mice Blood. 83: 1690-1697. DOI: 10.1182/Blood.V83.6.1690.Bloodjournal8361690 |
0.329 |
|
| 1994 |
Harroch S, Revel M, Chebath J. Induction by interleukin-6 of interferon regulatory factor 1 (IRF-1) gene expression through the palindromic interferon response element pIRE and cell type-dependent control of IRF-1 binding to DNA. The Embo Journal. 13: 1942-1949. DOI: 10.1002/J.1460-2075.1994.Tb06463.X |
0.373 |
|
| 1993 |
Katz A, Shulman LM, Revel M, Feldman M, Eisenbach L. Combined therapy with IL-6 and inactivated tumor cells suppresses metastasis in mice bearing 3LL lung carcinomas International Journal of Cancer. 53: 812-818. PMID 8449606 DOI: 10.1002/Ijc.2910530518 |
0.336 |
|
| 1993 |
Katz A, Shulman LM, Porgador A, Revel M, Feldman M, Eisenbach L. Abrogation of b16 melanoma metastases by long-term low-dose interleukin-6 therapy Journal of Immunotherapy. 13: 98-109. PMID 8318501 DOI: 10.1097/00002371-199302000-00004 |
0.317 |
|
| 1993 |
Aderka D, Maor Y, Novick D, Engelmann H, Kahn Y, Levo Y, Wallach D, Revel M. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta Blood. 81: 2076-2084. DOI: 10.1182/Blood.V81.8.2076.2076 |
0.325 |
|
| 1992 |
Novick D, Shulman LM, Chen L, Revel M. Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody. Cytokine. 4: 6-11. PMID 1617157 DOI: 10.1016/1043-4666(92)90029-Q |
0.303 |
|
| 1992 |
Givon T, Slavin S, Haran-Ghera N, Michalevicz R, Revel M. Antitumor effects of human recombinant interleukin-6 on acute myeloid leukemia in mice and in cell cultures Blood. 79: 2392-2398. DOI: 10.1182/Blood.V79.9.2392.Bloodjournal7992392 |
0.349 |
|
| 1992 |
Revel M, Harroch S, Gothel Y, Chebath J. 89. Differentiation of myeloleukemic M1 cells: role of early gene activations by IL-6 and IFN Biomedicine & Pharmacotherapy. 46: 282. DOI: 10.1016/0753-3322(92)90174-6 |
0.338 |
|
| 1991 |
Kaufmann Y, Davidsohn J, Levanon M, Icekson I, Revel M, Ramot B. Lymphokine-activated killer (LAK) cells: I Interferon-γ synergizes with interleukin-2 to induce LAK cytotoxicity in homogeneous leukemic preparations Clinical Immunology and Immunopathology. 58: 278-288. PMID 1898716 DOI: 10.1016/0090-1229(91)90142-W |
0.341 |
|
| 1991 |
Cohen B, Gothelf Y, Vaiman D, Chen L, Revel M, Chebath J. Interleukin-6 induces the (2'-5') oligoadenylate synthetase gene in M1 cells through an effect on the interferon-responsive enhancer. Cytokine. 3: 83-91. PMID 1888886 DOI: 10.1016/1043-4666(91)90027-B |
0.358 |
|
| 1990 |
Novick D, Engelmann H, Wallach D, Leitner O, Revel M, Rubinstein M. Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography. Journal of Chromatography A. 510: 331-337. PMID 2144854 DOI: 10.1016/S0021-9673(01)93767-7 |
0.311 |
|
| 1989 |
Michalevicz R, Aderka D, Frisch B, Revel M. Interferon-beta induced remission in a hairy cell leukemia patient resistant to interferon-alpha. Leukemia Research. 12: 845-51. PMID 3199843 DOI: 10.1016/0145-2126(88)90038-0 |
0.305 |
|
| 1989 |
Novick D, Eshhar Z, Revel M, Mory Y. Monoclonal antibodies for affinity purification of IL-6/IFN- beta 2 and for neutralization of HGF activity. Hybridoma. 8: 561-7. PMID 2680901 DOI: 10.1089/Hyb.1989.8.561 |
0.358 |
|
| 1989 |
Katz Y, Revel M, Strunk RC. Interleukin 6 stimulates synthesis of complement proteins factor B and C3 in human skin fibroblasts. European Journal of Immunology. 19: 983-8. PMID 2473911 DOI: 10.1002/Eji.1830190605 |
0.346 |
|
| 1988 |
Sancéau J, Falcoff R, Zilberstein A, Béranger F, Lebeau J, Revel M, Vaquero C. Interferon-beta 2 (BSF-2) mRNA is expressed in human monocytes. Journal of Interferon Research. 8: 473-81. PMID 3171244 DOI: 10.1089/Jir.1988.8.473 |
0.313 |
|
| 1988 |
Chen L, Novick D, Rubinstein M, Revel M. Recombinant interferon-beta 2 (interleukin-6) induces myeloid differentiation. Febs Letters. 239: 299-304. PMID 3141215 DOI: 10.1016/0014-5793(88)80939-6 |
0.343 |
|
| 1988 |
Chen L, Mory Y, Zilberstein A, Revel M. Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2 Proceedings of the National Academy of Sciences of the United States of America. 85: 8037-8041. PMID 3054878 DOI: 10.1073/Pnas.85.21.8037 |
0.339 |
|
| 1988 |
Aderka D, Levo Y, Ramot B, Michalevicz R, Meytes D, Shaklai M, Hahn T, Holtmann H, Revel M, Wallach D. Reduced production of tumor necrosis factor by mononuclear cells in hairy cell leukemia patients and improvement following interferon therapy. Cancer. 60: 2208-12. PMID 2830954 DOI: 10.1002/1097-0142(19871101)60:9<2208::Aid-Cncr2820600917>3.0.Co;2-8 |
0.339 |
|
| 1988 |
Shabo Y, Lotem J, Rubinstein M, Revel M, Clark S, Wolf S, Kamen R, Sachs L. The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6 Blood. 72: 2070-2073. DOI: 10.1182/Blood.V72.6.2070.2070 |
0.356 |
|
| 1987 |
Benech P, Vigneron M, Peretz D, Revel M, Chebath J. Interferon-responsive regulatory elements in the promoter of the human 2',5'-oligo(A) synthetase gene. Molecular and Cellular Biology. 7: 4498-4504. PMID 2830497 DOI: 10.1128/Mcb.7.12.4498 |
0.331 |
|
| 1987 |
Chebath J, Benech P, Revel M, Vigneron M. Constitutive expression of (2'-5') oligo A synthetase confers resistance to picornavirus infection. Nature. 330: 587-588. PMID 2825034 DOI: 10.1038/330587A0 |
0.33 |
|
| 1986 |
Sehgal PB, Zilberstein A, Ruggieri RM, May LT, Ferguson-Smith A, Slate DL, Revel M, Ruddle FH. Human chromosome 7 carries the β2 interferon gene Proceedings of the National Academy of Sciences of the United States of America. 83: 5219-5222. PMID 3014537 DOI: 10.1073/Pnas.83.14.5219 |
0.319 |
|
| 1986 |
Revel M, Chebath J. Interferon-activated genes Trends in Biochemical Sciences. 11: 166-170. DOI: 10.1016/0968-0004(86)90134-9 |
0.375 |
|
| 1986 |
Zilberstein A, Ruggieri R, Korn JH, Revel M. Structure and expression of cDNA and genes for human interferon‐beta‐2, a distinct species inducible by growth‐stimulatory cytokines. The Embo Journal. 5: 2529-2537. DOI: 10.1002/J.1460-2075.1986.Tb04531.X |
0.353 |
|
| 1985 |
Benech P, Merlin G, Revel M, Chebath J. 3′ End structure of the human (2′–5′) oligo A synthetase gene: prediction of two distinct proteins with cell type-specific expression Nucleic Acids Research. 13: 1267-1281. PMID 2860635 DOI: 10.1093/Nar/13.4.1267 |
0.332 |
|
| 1985 |
Benech P, Mory Y, Revel M, Chebath J. Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences. The Embo Journal. 4: 2249-2256. DOI: 10.1002/J.1460-2075.1985.Tb03922.X |
0.365 |
|
| 1984 |
Gazitt Y, Ben-Bassat H, Wallach D, Revel M, Schattner A. Interferon-induced cytotoxicity and (2'-5') oligo(A) synthetase activity in T cells. Differences in responsiveness among T cells from various individuals and among lymphoblastoid T-cell lines. Clinical Immunology and Immunopathology. 30: 71-9. PMID 6607796 DOI: 10.1016/0090-1229(84)90008-4 |
0.327 |
|
| 1984 |
Yarden A, Shure-Gottlieb H, Chebath J, Revel M, Kimchi A. Autogenous production of interferon-beta switches on HLA genes during differentiation of histiocytic lymphoma U937 cells Embo Journal. 3: 969-973. PMID 6376119 DOI: 10.1002/J.1460-2075.1984.Tb01915.X |
0.377 |
|
| 1984 |
Nir U, Cohen B, Chen L, Revel M. A human IFN-β1, gene deleted of promoter sequences upstream from the TATA box is controlled post-transcriptionally by dsRNA Nucleic Acids Research. 12: 6979-6993. PMID 6091048 DOI: 10.1093/Nar/12.18.6979 |
0.356 |
|
| 1983 |
Merlin G, Chebath J, Benech P, Metz R, Revel M. Molecular cloning and sequence of partial cDNA for interferon-induced (2'-5')oligo(A) synthetase mRNA from human cells Proceedings of the National Academy of Sciences of the United States of America. 80: 4904-4908. PMID 6348777 DOI: 10.1073/Pnas.80.16.4904 |
0.365 |
|
| 1983 |
Malpièce Y, Michel ML, Carloni G, Revel M, Tiollais P, Weissenbach J. The gene S promoter of hepatitis B virus confers constitutive gene expression. Nucleic Acids Research. 11: 4645-54. PMID 6306597 DOI: 10.1093/Nar/11.13.4645 |
0.304 |
|
| 1983 |
Maroteaux L, Chen L, Mitrani-Rosenbaum S, Howley PM, Revel M. Cycloheximide induces expression of the human interferon beta 1 gene in mouse cells transformed by bovine papillomavirus-interferon beta 1 recombinants. Journal of Virology. 47: 89-95. PMID 6306284 DOI: 10.1128/Jvi.47.1.89-95.1983 |
0.354 |
|
| 1983 |
Mitrani-Rosenbaum S, Maroteaux L, Mory Y, Revel M, Howley PM. Inducible expression of the human interferon beta 1 gene linked to a bovine papilloma virus DNA vector and maintained extrachromosomally in mouse cells. Molecular and Cellular Biology. 3: 233-40. PMID 6300659 DOI: 10.1128/Mcb.3.2.233 |
0.313 |
|
| 1983 |
Chebath J, Merlin G, Metz R, Benech P, Revel M. Interferon-induced 56,000 Mr protein and its mRNA in human cells: molecular cloning and partial sequence of the cDNA Nucleic Acids Research. 11: 1213-1226. PMID 6186990 DOI: 10.1093/Nar/11.5.1213 |
0.375 |
|
| 1983 |
Rosa F, Fellous M, Dron M, Tovey M, Revel M. Presence of an abnormal beta 2-microglobulin mRNA in Daudi cells: induction by interferon. Immunogenetics. 17: 125-31. PMID 6186603 DOI: 10.1007/Bf00364752 |
0.34 |
|
| 1983 |
Maroteaux L, Kahana C, Mory Y, Groner Y, Revel M. Sequences involved in the regulated expression of the human interferon-beta1 gene in recombinant SV40 DNA vectors replicating in monkey cells. The Embo Journal. 2: 325-332. DOI: 10.1002/J.1460-2075.1983.Tb01426.X |
0.349 |
|
| 1982 |
Wallach D, Fellous M, Revel M. Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature. 299: 833-6. PMID 6290893 DOI: 10.1038/299833A0 |
0.369 |
|
| 1982 |
Schattner A, Wallach D, Merlin G, Hahn T, Levin S, Ramot B, Revel M. Variation of (2'-5') oligo A synthetase level in lymphocytes and granulocytes of patients with viral infections and leukemia. Journal of Interferon Research. 2: 355-61. PMID 6182252 DOI: 10.1089/Jir.1982.2.355 |
0.309 |
|
| 1982 |
Schattner A, Merlin G, Wallach D, Rosenberg H, Bino T, Hahn T, Levin S, Revel M. Monitoring of interferon therapy by assay of (2'--5') oligo-isoadenylate synthetase in human peripheral white blood cells. Journal of Interferon Research. 1: 587-94. PMID 6180091 DOI: 10.1089/Jir.1981.1.587 |
0.322 |
|
| 1981 |
Revel M, Wallach D, Merlin G, Schattner A, Schmidt A, Wolf D, Shulman L, Kimchi A. [20] Interferon-induced enzymes: Microassays and their applications; purification and assay of (2′-5′)-oligoadenylate synthetase and assay of 2′-phosphodiesterase Methods in Enzymology. 79: 149-161. PMID 6173659 DOI: 10.1016/S0076-6879(81)79024-4 |
0.301 |
|
| 1981 |
Kimchi A, Shure H, Lapidot Y, Rapoport S, Panet A, Revel M. Antimitogenic effects of interferon and (2′-5′)-oligoadenylate in synchronized 3T3 fibroblasts Febs Letters. 134: 212-216. PMID 6171460 DOI: 10.1016/0014-5793(81)80604-7 |
0.362 |
|
| 1981 |
Schattner A, Merlin G, Levin S, Wallach D, Hahn T, Revel M. Assay Of An Interferon-Induced Enzyme In White Blood Cells As A Diagnostic Aid In Viral Diseases The Lancet. 318: 497-500. PMID 6167829 DOI: 10.1016/S0140-6736(81)90883-7 |
0.31 |
|
| 1981 |
Kahana C, Yakobson E, Revel M, Groner Y. Increased methylation of RNA in SV40-infected interferon-treated cells. Virology. 112: 109-18. PMID 6166121 DOI: 10.1016/0042-6822(81)90617-6 |
0.325 |
|
| 1981 |
KIMCHI A, SHURE H, REVEL M. Anti‐mitogenic Function of Interferon‐Induced (2′‐5′)Oligo(adenylate) and Growth‐Related Variations in Enzymes that Synthesize and Degrade This Oligonucleotide European Journal of Biochemistry. 114: 5-10. PMID 6163628 DOI: 10.1111/J.1432-1033.1981.Tb06163.X |
0.331 |
|
| 1980 |
Shulman L, Revel M. Interferon-dependent induction of mRNA activity for (2'-5')oligo-isoadenylate synthetase. Nature. 288: 98-100. PMID 6159548 DOI: 10.1038/288098A0 |
0.359 |
|
| 1980 |
Wallach D, Revel M. An interferon-induced cellular enzyme is incorporated into virions Nature. 287: 68-70. PMID 6157996 DOI: 10.1038/287068A0 |
0.313 |
|
| 1979 |
Kimchi A, Shure H, Revel M. Regulation of lymphocyte mitogenesis by (2'-5') oligo-isoadenylate [22] Nature. 282: 849-851. PMID 514363 DOI: 10.1038/282849A0 |
0.367 |
|
| 1979 |
Weissenbach J, Zeevi M, Landau T, Revel M. Identification of the Translation Products of Human Fibroblast Interferon mRNA in Reticulocyte Lysates Febs Journal. 98: 1-8. PMID 467436 DOI: 10.1111/J.1432-1033.1979.Tb13153.X |
0.34 |
|
| 1979 |
Chernajovsky Y, Kimchi A, Schmidt A, Zilberstein A, Revel M. Differential effects of two interferon-induced translational inhibitors on initiation of protein synthesis. European Journal of Biochemistry. 96: 35-41. PMID 456366 DOI: 10.1111/J.1432-1033.1979.Tb13010.X |
0.359 |
|
| 1979 |
Zilberstein A, Kimchi A, Schmidt A, Revel M. Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase. Proceedings of the National Academy of Sciences of the United States of America. 75: 4734-8. PMID 283387 DOI: 10.1073/Pnas.75.10.4734 |
0.317 |
|
| 1979 |
Kaempfer R, Israeli R, Rosaeli H, Knoller S, Zilberstein A, Schmidt A, Revel M. Reversal of the interferon-induced block of protein synthesis by purified preparations of eucaryotic initiation factor 2. Virology. 99: 170-173. PMID 227160 DOI: 10.1016/0042-6822(79)90049-7 |
0.362 |
|
| 1979 |
Yakobson E, Revel M, Gurari-Rotman D. Monkey interferon: Activity on human cells and chromatographic properties Archives of Virology. 59: 251-255. PMID 222238 DOI: 10.1007/Bf01317420 |
0.332 |
|
| 1979 |
Wallach D, Revel M. Hormonal protection of interferon-treated cells against double-stranded RNA-induced cytolysis Febs Letters. 101: 364-368. PMID 221265 DOI: 10.1016/0014-5793(79)81045-5 |
0.387 |
|
| 1979 |
Salzberg S, Heller A, Aboud M, Gurari-Rotman D, Revel M. Effect of interferon on human cells releasing oncornaviruses: an assay for human interferon. Virology. 93: 209-214. PMID 86229 DOI: 10.1016/0042-6822(79)90288-5 |
0.342 |
|
| 1978 |
Schmidt A, Zilberstein A, Shulman L, Federman P, Berissi H, Revel M. Interferon action: Isolation of Nuclease F, A translation inhibitor activated by interferon-induced (2′–5′) oligo-isoadenylate Febs Letters. 95: 257-264. PMID 720619 DOI: 10.1016/0014-5793(78)81006-0 |
0.359 |
|
| 1978 |
Revel M, Gilboa E, Kimchi A, Schmidt A, Shulman L, Yakobson E, Zilberstein A. Interferon-induced translational regulation. Texas Reports On Biology and Medicine. 35: 47-58. DOI: 10.1016/B978-0-08-022624-8.50011-9 |
0.398 |
|
| 1977 |
Yaron M, Yaron I, Gurari-Rotman D, Revel M, Lindner HR, Zor U. Stimulation of prostaglandin E production in cultured human fibroblasts by poly(I)-poly(C) and human interferon. Nature. 267: 457-9. PMID 876363 DOI: 10.1038/267457A0 |
0.309 |
|
| 1977 |
Yakobson E, Prives C, Hartman JR, Winocour E, Revel M. Inhibition of viral protein synthesis in monkey cells treated with interferon late in simian virus 40 lytic cycle. Cell. 12: 73-81. PMID 198143 DOI: 10.1016/0092-8674(77)90186-6 |
0.32 |
|
| 1977 |
Prives C, Gilboa E, Revel M, Winocour E. Cell-free translation of simian virus 40 early messenger RNA coding for viral T-antigen. Proceedings of the National Academy of Sciences of the United States of America. 74: 457-61. PMID 191809 DOI: 10.1073/Pnas.74.2.457 |
0.319 |
|
| 1976 |
Zilberstein A, Federman P, Shulman L, Revel M. Specific phosphorylation in vitro of a protein associated with ribosomes of interferon-treated mouse L cells. Febs Letters. 68: 119-124. PMID 964373 DOI: 10.1016/0014-5793(76)80418-8 |
0.313 |
|
| 1976 |
Canaani D, Revel M, Groner Y. Translational discrimination of 'capped' and 'non-capped' mRNAS: inhibition of a series of chemical analogs of m7GpppX. Febs Letters. 64: 326-31. PMID 179883 DOI: 10.1016/0014-5793(76)80321-3 |
0.315 |
|
| 1975 |
Prives CL, Aviv H, Gilboa E, Revel M, Winocour E. The cell-free translation of SV40 messenger RNA. Cold Spring Harbor Symposia On Quantitative Biology. 39: 309-16. PMID 169074 DOI: 10.1101/Sqb.1974.039.01.041 |
0.307 |
|
| 1975 |
Nudel U, Zilberstein A, Berissi H, Revel M, Lebleu B. Blocks in elongation and initiation of protein synthesis induced by interferon treatment in mouse L cells. Febs Journal. 54: 1-10. PMID 168074 DOI: 10.1111/J.1432-1033.1975.Tb04106.X |
0.322 |
|
| 1974 |
Revel M, Groner Y, Pollack Y, Cnaani D, Zeller H, Nudel U. mRNA specific initiation factors in the control of protein synthesis. Advances in Experimental Medicine and Biology. 44: 99-122. PMID 4601259 DOI: 10.1007/978-1-4684-3246-6_9 |
0.332 |
|
| 1974 |
Lebleu B, Zilberstein A, Berissi H, Revel M. Mechanism of the interferon-induced block of mRNA translation in mouse L cells: Reversal of the block by transfer RNA Febs Letters. 41: 125-130. PMID 4368899 DOI: 10.1016/0014-5793(74)80970-1 |
0.394 |
|
| 1974 |
Prives CL, Aviv H, Paterson BM, Roberts BE, Rozenblatt S, Revel M, Winocour E. Cell-free translation of messenger RNA of simian virus 40: synthesis of the major capsid protein. Proceedings of the National Academy of Sciences of the United States of America. 71: 302-6. PMID 4360938 DOI: 10.1073/Pnas.71.2.302 |
0.318 |
|
| 1974 |
Groner Y, Revel M. Purification and properties of interference factor I: a cistron-specific translation control factor and a subunit of phage RNA replicase. Methods in Enzymology. 30: 68-78. PMID 4212289 DOI: 10.1016/0076-6879(74)30010-9 |
0.313 |
|
| 1974 |
Lieberman D, Voloch Z, Aviv H, Nudel U, Revel M. Effects of interferon on hemoglobin synthesis and leukemia virus production in Friend cells Molecular Biology Reports. 1: 447-451. PMID 4141750 DOI: 10.1007/Bf00360670 |
0.344 |
|
| 1973 |
Nudel U, Lebleu B, Revel M, Zehavi-Willner T. Messenger Ribonucleoprotein and Initiation Factors in Rabbit‐Reticulocyte Polyribosomes Febs Journal. 33: 314-322. PMID 4632818 DOI: 10.1111/J.1432-1033.1973.Tb02685.X |
0.304 |
|
| 1973 |
Revel M, Pollack Y, Groner Y, Scheps R, Inouye H, Berissi H, Zeller H. IF3-interference factors: protein factors in Escherichia coli controlling initiation of mRNA translation. Biochimie. 55: 41-51. PMID 4578554 DOI: 10.1016/S0300-9084(73)80235-4 |
0.317 |
|
| 1973 |
Falcoff E, Falcoff R, Lebleu B, Revel M. Correlation Between the Antiviral Effect of Interferon Treatment and the Inhibition of In Vitro mRNA Translation in Noninfected L cells Journal of Virology. 12: 421-430. PMID 4355848 DOI: 10.1128/Jvi.12.3.421-430.1973 |
0.369 |
|
| 1973 |
Nudel U, Lebleu B, Revel M. Discrimination between messenger ribonucleic acids by a mammalian translation initiation factor. Proceedings of the National Academy of Sciences of the United States of America. 70: 2139-2144. PMID 4352974 DOI: 10.1073/Pnas.70.7.2139 |
0.317 |
|
| 1972 |
Lebleu B, Nudel U, Falcoff E, Prives C, Revel M. A comparison of the translation of Mengo virus RNA and globin mRNA in krebs ascites cell-free extracts. Febs Letters. 25: 97-103. PMID 11946730 DOI: 10.1016/0014-5793(72)80463-0 |
0.308 |
|
| 1972 |
Scheps R, Revel M. Deficiency in initiation factors of protein synthesis in stationary-phase Escherichia coli. Febs Journal. 29: 319-325. PMID 4628224 DOI: 10.1111/J.1432-1033.1972.Tb01991.X |
0.342 |
|
| 1972 |
Groner Y, Pollack Y, Berissi H, Revel M. Cistron specific translation control protein in Escherichia coli. Nature: New Biology. 239: 16-9. PMID 4562228 DOI: 10.1038/Newbio239016A0 |
0.314 |
|
| 1972 |
Falcoff E, Falcoff R, Lebleu B, Revel M. Interferon treatment inhibits Mengo RNA and haemoglobin mRNA translation in cell-free extracts of L cells. Nature. 240: 145-147. PMID 4345005 DOI: 10.1038/Newbio240145A0 |
0.378 |
|
| 1969 |
Herzberg M, Danon D, Revel M. The Influence of Ribosomal Factors during the Maturation of Reticulocytes Febs Journal. 11: 148-153. PMID 5353598 DOI: 10.1111/J.1432-1033.1969.Tb00752.X |
0.323 |
|
| 1968 |
Revel M, Herzberg M, Becarevic A, Gros F. Role of protein factor in the functional binding of ribosomes to natural messenger RNA. Journal of Molecular Biology. 33: 231-49. PMID 4869226 DOI: 10.1016/0022-2836(68)90291-X |
0.305 |
|
| Show low-probability matches. |